Decline depth
-22.4%
From rolling 252-day high of $93.42, 63d ago.
Past the 20% Watch threshold.
-22.4%
from rolling 252-day high of $93.42 set 2026-07-09 · 63d ago
Current
$72.50
Decline depth
-22.4%
Decline σ
8.8σ
TFC
3/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Since it joined the list
$BBIO landed on the list 2026-05-07, down 20.6% from its 52-week high that day — now down -22.4%.
It has clawed back 5.9 percentage points off that level. It bottomed 24.8% below that high along the way.
From the 52-week high as of 2026-05-07 to today. Split-adjusted. Observed, not a forecast.
Structural break signals
BBIO qualifies for the Red List on decline depth.
Time-frame continuity
3/5 bearish
Latest bar on five time frames, daily to yearly. Bearish = 2-Down or red 3.
Past the 3/5 Watch threshold.
Decline sigma
8.8σ
Drop over the last 20 bars in units of daily volatility (1.8%/day).
Past the ≥8σ Red List threshold — an extreme move.
The structural read
What price action says about BBIO.
BBIO qualifies for the Red List on decline depth — down -22.4% from its rolling 252-day high. Past 30% with the high set inside the last four months — the recency clause that often precedes further breakdown.
Cross-confirmation: also showing 3/5 bearish time frames.
Cross-confirmation: decline sigma also reads 8.8σ over 20 bars.
Upstream TFC read: bearish alignment, current phase daily. Last bar types — daily 2D (red), weekly 2D (red), monthly 2D (red).
Earnings on file: 2026-05-07. Earnings dates don't affect tiering.
Questions about BBIO
What people ask.
Why is BBIO on Broken Stocks?
BBIO qualifies for the Red List on decline depth. It is down -22.4% from its rolling 252-day high of $93.42, set on 2026-07-09 — 63d ago.
Is BBIO a falling knife?
No. The falling-knife label usually implies a steep, severe drop — typically 30% or more from a fresh high. BBIO is down -22.4% from its 52-week high, which qualifies for the Watch tier but is shallower than the falling-knife pattern. It's an early-stage decline rather than a sharp breakdown.
Is BBIO a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is BBIO trading inside its 52-week range?
At $72.50, BBIO sits 73.7% of the way from its 52-week low ($37.57) to its 52-week high ($84.94). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has BBIO been declining?
The current 22.4% decline accrued over 63d, which annualizes to roughly -129.8% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does BBIO compare to its sector?
There are 283 other Healthcare tickers on Broken Stocks: 155 Red, 79 Amber, 49 Watch, with 28 showing recovering structural signals. Median sector decline is -36.0% — BBIO's decline is shallower than the sector median.
Does BBIO's earnings date affect its tier?
No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-07) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.